Mayo Clinic Care Network Content
Articles

Serotonin and norepinephrine reuptake inhibitors (SNRIs)

SNRIs approved to treat depression

The U.S. Food and Drug Administration, also called the FDA, has approved these SNRIs to treat depression:

  • Desvenlafaxine (Pristiq).
  • Duloxetine (Cymbalta, Drizalma Sprinkle). This medicine also is approved to treat generalized anxiety disorder and certain types of pain, such as fibromyalgia pain.
  • Levomilnacipran (Fetzima).
  • Venlafaxine (Effexor XR). This medicine also is approved to treat generalized anxiety disorder, social anxiety disorder and panic disorder.